Adult T Cell Leukemia (ATL) Terminated Phase 0 Trials for Lenalidomide (DB00480)

Also known as: Adult T-Cell Leukemia (ATL) / T Cell Leukemia, Adult / Adult T Cell Leukemia / Leukemia, Adult T-Cell / Adult T-Cell Leukemia

IndicationStatusPhase
DBCOND0040418 (Adult T Cell Leukemia (ATL))Terminated0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00704691Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell LymphomasTreatment